Immunovia’s Pancreatic Cancer Test Up and Running at New Lab
Immunovia’s new lab is now fully operational, marking a significant step towards enhancing early detection of pancreatic cancer.
Read MorePosted by Chris Wolski | Jul 4, 2024 | Pancreatic |
Immunovia’s new lab is now fully operational, marking a significant step towards enhancing early detection of pancreatic cancer.
Read MorePosted by Andy Lundin | Jun 27, 2024 | Compliance |
An ADLM survey found that the FDA’s LDT final rule will likely reduce patient access to crucial tests, despite exemptions to mitigate this.
Read MorePosted by Chris Wolski | Jun 26, 2024 | Womens Health |
Recent advancements in congenital CMV (cCMV) screening underscore the need for enhanced awareness and legislative action.
Read MorePosted by Chris Wolski | Jun 4, 2024 | Point-of-Care |
The diagnostic-to-treatment continuum is backward, with tests conducted after consultations, a shift in the paradigm could improve care.
Read MorePosted by Andy Lundin | Jun 4, 2024 | Gastrointestinal Infections |
The FDA approved Genetic Signatures’ EasyScreen Gastrointestinal Parasite Detection Kit and GS1 automated workflow for sale in the U.S.
Read More